Work from Hovanessian’s lab suggests that differential expression of nucleolin on the cell surface of cancer cells results from constitutive cell surface trafficking of nucleolin, compared to mitogen-dependent nucleolin cell surface trafficking in normal cells38. The gene discussed is NUCLEOLIN; the disease is cancer.